The Division of AIDS Office of International Programs sponsors an annual international workshop on treatment, care, and prevention of HIV/AIDS annually.
South Africa Workshop, October 2006
Over 200 health care workers, academics, and policy makers who participated in the "Realities of ART Roll-Out: Overcoming Challenges to Successful Programmatic Implementation Conference" workshop co-sponsored by the Medical Research Council of South Africa, the Department of Health of KZN and the Nelson Mandela School of Medicine and Harvard University. The workshop was held in Durban, South Africa from October 4th through 7th.
This event was timely and addressed some of the most critical needs facing ART treatment expansion in resource limited settings.
The presentations (video and power points) are available at: www.hms.harvard.edu/aids/news/symposiasymposiums/southafricaworkshop.htm
When to Switch Workshop, November 2004
On Nov. 12, 2004, more than 70 people from 16 countries representing physicians, researchers, public health policy makers, scientists, and NGOs gathered in Boston to frame these issues in anticipation of moving quickly to more formal discussions and guidelines. The daylong meeting,
"When to Switch HIV Antiviral Therapy in Resource-Limited Settings," was convened and hosted by the Harvard Medical School Division of AIDS.
When to Switch proceedings (PDF 385k)
Vietnam Workshop, July 2004
The Second Annual HMS Division of AIDS International Workshop was held in Vietnam, July 5-9, 2004. The emphasis of this workshop addressed building AIDS treatment capacity using the already existing TB program in Vietnam.
Haiti Workshop, April 2003
In April of 2003, the Harvard Medical School Division of AIDS, PIH, and GHESKIO sponsored an international workshop in Haiti on treating HIV/AIDS in resource-poor settings. "Moving from Models to Implementation: Haiti Workshop on Expanding AIDS Treatment, Care, and Prevention in Resource-Poor Settings" brought together 60 persons including clinicians involved in trials of anti-HIV therapies from developed and developing countries, global AIDS treatment funding agents and policy makers, and key U.S. government scientists to participate in a two day discussion of what has been learned thus far and what can realistically be done to provide optimal care. This was the first such meeting to concretely articulate scale-up needs and best practices for treatment in resource poor settings, with or without CD4 and viral load assays.
Haiti proceedings (PDF 400k)
 |
